Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Merz Venture Initiative

Corporate venture profile

Parent Merz Pharma

Merz Venture Initiative is the corporate venture arm of Merz Pharma, a pharmaceutical and biotech company. It invests at the Series A stage. Sectors it names: medical devices, biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Series A to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series A
SectorsMedical devices, Biotech and life sciences
GeographyGlobal

Sources: S1 Merz Venture Initiative.

Graphic 1 of 1

Investment stage: Series A to Series A

Sources: S1 Merz Venture Initiative.

Download:Report a correction

Where it invests

Geography

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyMerz PharmaSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeries A (inferred from announced rounds)EstimateS1

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2024-01-31Acorn BiolabsSeries AUSD 8MYesS4

Portfolio

Portfolio companies named in public sources: Cytrellis Biosystems, Acorn Biolabs.S3

Official pages

Read the firm's own pages for current information.

  • Website www.merz.com/venture-initiative/

Sources

  1. S1Merz Venture InitiativeFirm
  2. S3Merz Venture Initiative increases investment in CytrellisParent company
  3. S4AMSPA: Merz Aesthetics leads Series A funding of Acorn Biolabs (2024-01-31)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Merz Venture Initiative or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.